2023-10-012024-09-302024-09-30false12214947UROLOGY CARE UK LTD2025-06-30falseiso4217:GBPxbrli:pure122149472023-10-01122149472024-09-30122149472023-10-012024-09-30122149472022-10-01122149472023-09-30122149472022-10-012023-09-3012214947bus:SmallEntities2023-10-012024-09-3012214947bus:AuditExempt-NoAccountantsReport2023-10-012024-09-3012214947bus:FullAccounts2023-10-012024-09-3012214947bus:PrivateLimitedCompanyLtd2023-10-012024-09-3012214947core:WithinOneYear2024-09-3012214947core:AfterOneYear2024-09-3012214947core:WithinOneYear2023-09-3012214947core:AfterOneYear2023-09-3012214947core:ShareCapital2024-09-3012214947core:SharePremium2024-09-3012214947core:RevaluationReserve2024-09-3012214947core:OtherReservesSubtotal2024-09-3012214947core:RetainedEarningsAccumulatedLosses2024-09-3012214947core:ShareCapital2023-09-3012214947core:SharePremium2023-09-3012214947core:RevaluationReserve2023-09-3012214947core:OtherReservesSubtotal2023-09-3012214947core:RetainedEarningsAccumulatedLosses2023-09-3012214947core:LandBuildings2024-09-3012214947core:PlantMachinery2024-09-3012214947core:Vehicles2024-09-3012214947core:FurnitureFittings2024-09-3012214947core:OfficeEquipment2024-09-3012214947core:NetGoodwill2024-09-3012214947core:IntangibleAssetsOtherThanGoodwill2024-09-3012214947core:ListedExchangeTraded2024-09-3012214947core:UnlistedNon-exchangeTraded2024-09-3012214947core:LandBuildings2023-09-3012214947core:PlantMachinery2023-09-3012214947core:Vehicles2023-09-3012214947core:FurnitureFittings2023-09-3012214947core:OfficeEquipment2023-09-3012214947core:NetGoodwill2023-09-3012214947core:IntangibleAssetsOtherThanGoodwill2023-09-3012214947core:ListedExchangeTraded2023-09-3012214947core:UnlistedNon-exchangeTraded2023-09-3012214947core:LandBuildings2023-10-012024-09-3012214947core:PlantMachinery2023-10-012024-09-3012214947core:Vehicles2023-10-012024-09-3012214947core:FurnitureFittings2023-10-012024-09-3012214947core:OfficeEquipment2023-10-012024-09-3012214947core:NetGoodwill2023-10-012024-09-3012214947core:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3012214947core:ListedExchangeTraded2023-10-012024-09-3012214947core:UnlistedNon-exchangeTraded2023-10-012024-09-3012214947core:MoreThanFiveYears2023-10-012024-09-3012214947core:Non-currentFinancialInstruments2024-09-3012214947core:Non-currentFinancialInstruments2023-09-3012214947dpl:CostSales2023-10-012024-09-3012214947dpl:DistributionCosts2023-10-012024-09-3012214947core:LandBuildings2023-10-012024-09-3012214947core:PlantMachinery2023-10-012024-09-3012214947core:Vehicles2023-10-012024-09-3012214947core:FurnitureFittings2023-10-012024-09-3012214947core:OfficeEquipment2023-10-012024-09-3012214947dpl:AdministrativeExpenses2023-10-012024-09-3012214947core:NetGoodwill2023-10-012024-09-3012214947core:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3012214947dpl:GroupUndertakings2023-10-012024-09-3012214947dpl:ParticipatingInterests2023-10-012024-09-3012214947dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-012024-09-3012214947core:ListedExchangeTraded2023-10-012024-09-3012214947dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-012024-09-3012214947core:UnlistedNon-exchangeTraded2023-10-012024-09-3012214947dpl:CostSales2022-10-012023-09-3012214947dpl:DistributionCosts2022-10-012023-09-3012214947core:LandBuildings2022-10-012023-09-3012214947core:PlantMachinery2022-10-012023-09-3012214947core:Vehicles2022-10-012023-09-3012214947core:FurnitureFittings2022-10-012023-09-3012214947core:OfficeEquipment2022-10-012023-09-3012214947dpl:AdministrativeExpenses2022-10-012023-09-3012214947core:NetGoodwill2022-10-012023-09-3012214947core:IntangibleAssetsOtherThanGoodwill2022-10-012023-09-3012214947dpl:GroupUndertakings2022-10-012023-09-3012214947dpl:ParticipatingInterests2022-10-012023-09-3012214947dpl:GroupUndertakingscore:ListedExchangeTraded2022-10-012023-09-3012214947core:ListedExchangeTraded2022-10-012023-09-3012214947dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-10-012023-09-3012214947core:UnlistedNon-exchangeTraded2022-10-012023-09-3012214947core:NetGoodwill2024-09-3012214947core:IntangibleAssetsOtherThanGoodwill2024-09-3012214947core:LandBuildings2024-09-3012214947core:PlantMachinery2024-09-3012214947core:Vehicles2024-09-3012214947core:FurnitureFittings2024-09-3012214947core:OfficeEquipment2024-09-3012214947core:AfterOneYear2024-09-3012214947core:WithinOneYear2024-09-3012214947core:ListedExchangeTraded2024-09-3012214947core:UnlistedNon-exchangeTraded2024-09-3012214947core:ShareCapital2024-09-3012214947core:SharePremium2024-09-3012214947core:RevaluationReserve2024-09-3012214947core:OtherReservesSubtotal2024-09-3012214947core:RetainedEarningsAccumulatedLosses2024-09-3012214947core:NetGoodwill2023-09-3012214947core:IntangibleAssetsOtherThanGoodwill2023-09-3012214947core:LandBuildings2023-09-3012214947core:PlantMachinery2023-09-3012214947core:Vehicles2023-09-3012214947core:FurnitureFittings2023-09-3012214947core:OfficeEquipment2023-09-3012214947core:AfterOneYear2023-09-3012214947core:WithinOneYear2023-09-3012214947core:ListedExchangeTraded2023-09-3012214947core:UnlistedNon-exchangeTraded2023-09-3012214947core:ShareCapital2023-09-3012214947core:SharePremium2023-09-3012214947core:RevaluationReserve2023-09-3012214947core:OtherReservesSubtotal2023-09-3012214947core:RetainedEarningsAccumulatedLosses2023-09-3012214947core:NetGoodwill2022-10-0112214947core:IntangibleAssetsOtherThanGoodwill2022-10-0112214947core:LandBuildings2022-10-0112214947core:PlantMachinery2022-10-0112214947core:Vehicles2022-10-0112214947core:FurnitureFittings2022-10-0112214947core:OfficeEquipment2022-10-0112214947core:AfterOneYear2022-10-0112214947core:WithinOneYear2022-10-0112214947core:ListedExchangeTraded2022-10-0112214947core:UnlistedNon-exchangeTraded2022-10-0112214947core:ShareCapital2022-10-0112214947core:SharePremium2022-10-0112214947core:RevaluationReserve2022-10-0112214947core:OtherReservesSubtotal2022-10-0112214947core:RetainedEarningsAccumulatedLosses2022-10-0112214947core:AfterOneYear2023-10-012024-09-3012214947core:WithinOneYear2023-10-012024-09-3012214947core:Non-currentFinancialInstrumentscore:CostValuation2023-10-012024-09-3012214947core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-012024-09-3012214947core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-012024-09-3012214947core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-012024-09-3012214947core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-012024-09-3012214947core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-012024-09-3012214947core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3012214947core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3012214947core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3012214947core:Non-currentFinancialInstrumentscore:CostValuation2024-09-3012214947core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-3012214947core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-3012214947core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-3012214947core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-3012214947core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-3012214947core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-3012214947core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-3012214947core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-3012214947core:Non-currentFinancialInstrumentscore:CostValuation2023-09-3012214947core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-3012214947core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-3012214947core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-3012214947core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-3012214947core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-3012214947core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-3012214947core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-3012214947core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-3012214947bus:Director12023-10-012024-09-3012214947bus:Director22023-10-012024-09-30

UROLOGY CARE UK LTD

Registered Number
12214947
(England and Wales)

Unaudited Financial Statements for the Year ended
30 September 2024

UROLOGY CARE UK LTD
Company Information
for the year from 1 October 2023 to 30 September 2024

Directors

NKWAM, Nkwam Michael
NKWAM, Toyosi Ajiun, Dr

Registered Address

28 A The Hundred
Romsey
SO51 8BW

Registered Number

12214947 (England and Wales)
UROLOGY CARE UK LTD
Balance Sheet as at
30 September 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets31,131733
1,131733
Current assets
Debtors-2,829
Cash at bank and on hand147,946135,849
147,946138,678
Creditors amounts falling due within one year4(31,824)(62,983)
Net current assets (liabilities)116,12275,695
Total assets less current liabilities117,25376,428
Net assets117,25376,428
Capital and reserves
Called up share capital150150
Profit and loss account117,10376,278
Shareholders' funds117,25376,428
The financial statements were approved and authorised for issue by the Board of Directors on 30 June 2025, and are signed on its behalf by:
NKWAM, Nkwam Michael
Director
Registered Company No. 12214947
UROLOGY CARE UK LTD
Notes to the Financial Statements
for the year ended 30 September 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Office Equipment50
2.Average number of employees

20242023
Average number of employees during the year33
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 October 232,5982,598
Additions1,5281,528
At 30 September 244,1264,126
Depreciation and impairment
At 01 October 231,8651,865
Charge for year1,1301,130
At 30 September 242,9952,995
Net book value
At 30 September 241,1311,131
At 30 September 23733733
4.Creditors: amounts due within one year

2024

2023

££
Taxation and social security28,79627,724
Other creditors79033,019
Accrued liabilities and deferred income2,2382,240
Total31,82462,983